Revenue Cycle Insider

Question: Are there any new HCPCS injection codes I should be aware of? I feel like an update should have posted by now, but I haven’t seen anything.

Alaska Subscriber

Answer: Yes, there are quite a few new injection codes about to go live on July 1, 2025. Now is the perfect time to familiarize yourself with them. 

Here's a list of the new HCPCS injection codes you should review before July 1: 

• J0165 (Injection, epinephrine, not otherwise specified, 0.1 mg) 
• J0166 (Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg) 
• J0167 (Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg) 
• J0168 (Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg) 
• J0169 (Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg) 
• J0616 (Injection, metoprolol tartrate, 1 mg) 
• J0618 (Injection, calcium chloride, 2 mg) 
• J1163 (Injection, diltiazem hydrochloride, 0.5 mg) 
• J2312 (Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg) 
• J2313 (Injection, naloxone hydrochloride (zimhi), 0.01 mg) 
• J3373 (Injection, vancomycin hydrochloride, 10 mg) 
• J3374 (Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg)
• J3375 (Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg)
• J7356 (Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg)
• J9275 (Injection, cosibelimab-ipdl, 2 mg)
• J9341 (Injection, thiotepa (tepylute), 1 mg)
• Q5153 (Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg).

Lindsey Bush, BA, MA, CPC, Production Editor, AAPC